0.74% 0.0041

プレマーケット: .56 0.0029 +0.52%

Turnstone Biologics Corp (TSBX)

Turnstone Biologics Corp (TSBX) 最新ニュース

Turnstone Biologics Corp (TSBX)

Turnstone Biologics Corp (TSBX) 最新ニュース

Turnstone Biologics Corp. (NASDAQ:TSBX) Short Interest Update - Defense World

Turnstone Biologics stock hits 52-week low at $0.58 amid sharp decline - Investing.com

Analyzing Organovo (NASDAQ:ONVO) & Turnstone Biologics (NASDAQ:TSBX) - Defense World

Reviewing Krystal Biotech (NASDAQ:KRYS) & Turnstone Biologics (NASDAQ:TSBX) - Defense World

Turnstone Biologics stock plunges to 52-week low of $0.67 - Investing.com

Turnstone Biologics stock plunges to 52-week low of $0.67 By Investing.com - Investing.com Canada

Turnstone Biologics stock plunges to 52-week low of $0.67 By Investing.com - Investing.com UK

Taking on analysts’ expectations and winning: Turnstone Biologics Corp (TSBX) - SETE News

Investor’s Delight: Turnstone Biologics Corp (TSBX) Closes Strong at 0.70, Up 1.15 - The Dwinnex

Is Turnstone Biologics Corp (TSBX) a good investment opportunity? - US Post News

Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Significant Increase in Short Interest - Defense World

Turnstone Biologics stock plunges to 52-week low of $0.72 - Investing.com

Turnstone Biologics price target lowered to $10 from $12 at BofA - TipRanks

Tourmaline Bio (NASDAQ:TRML) versus Turnstone Biologics (NASDAQ:TSBX) Head-To-Head Review - Defense World

The time has not yet come to remove your chips from the table: Turnstone Biologics Corp (TSBX) - SETE News

Turnstone Biologics Corp’s results are impressive - US Post News

Turnstone Biologics (NASDAQ:TSBX) Price Target Cut to $3.75 by Analysts at Piper Sandler - Defense World

Turnstone Biologics shares target cut by Piper Sandler with no rating change - Investing.com

Turnstone Biologics shares target cut by Piper Sandler with no rating change - Investing.com Canada

TSBX’s Stock Market Adventure: -70.07% YTD Growth Amidst Volatility - The InvestChronicle

Market Momentum: Turnstone Biologics Corp (TSBX) Registers a -8.24 Decrease, Closing at 0.76 - The Dwinnex

SVB Securities slashes price target on Turnstone Biologics Corp [TSBX] – find out why. - The DBT News

Turnstone Biologics (NASDAQ:TSBX) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS - Defense World

Take off with Turnstone Biologics Corp (TSBX): Get ready for trading - SETE News

Turnstone Biologics stock plunges to 52-week low of $1.36 By Investing.com - Investing.com Canada

Why Is Turnstone Biologics Stock Trading Lower On Thursday?Turnstone Biologics (NASDAQ:TSBX) - Benzinga

Turnstone Biologics stock plunges to 52-week low of $1.36 By Investing.com - Investing.com India

Turnstone Biologics stock plunges to 52-week low of $1.36 - Investing.com

Turnstone Biologics stock plunges to 52-week low of $1.36 By Investing.com - Investing.com UK

Turnstone reports positive early trial results for cancer therapy - Investing.com

Turnstone reports positive early trial results for cancer therapy - Investing.com India

Turnstone Biologics Reports Encouraging Phase 1 Results - TipRanks

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - ForexTV.com

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - StockTitan

Turnstone Biologics reports Q2 EPS (92c), consensus (93c) - TipRanks

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer - StockTitan

Turnstone Biologics Corp. (TSBX): This Penny Stock is a ‘Strong Buy’ According to Analysts - Insider Monkey

Turnstone Biologics Corp. (TSBX): This Penny Stock is a ‘Strong Buy’ According to Analysts - Yahoo Finance

Turnstone Biologics Corp. (NASDAQ:TSBX) Short Interest Update - American Banking and Market News

Turnstone Biologics Corp. (NASDAQ:TSBX) Short Interest Down 20.5% in June - MarketBeat

Can you still get a good price for Turnstone Biologics Corp (TSBX) Shares at this point? – US Post News - US Post News

Investor's Delight: Turnstone Biologics Corp (TSBX) Closes Weak at 2.62, Down -12.37 – DWinneX - The Dwinnex

Can Turnstone Biologics (NASDAQ:TSBX) Afford To Invest In Growth? - Yahoo Finance

A Tale of Resilience: Turnstone Biologics Corp Amid Stock Market Turbulence - The InvestChronicle

Turnstone Biologics - The Pharma Letter

Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - Quantisnow

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference - Quantisnow

Turnstone Biologics Corp (TSBX) stock analysis: A simple moving average approach – US Post News - US Post News

Critical Survey: Turnstone Biologics (TSBX) & Its Rivals - Defense World

Reviewing Turnstone Biologics (TSBX) & Its Competitors - Defense World

Head to Head Contrast: Turnstone Biologics (TSBX) and The Competition - Defense World

Are Smart Investors Making the Right Decision? Turnstone Biologics Corp (TSBX) – Sete News - SETE News

Quarterly Metrics: Quick and Current Ratios for Turnstone Biologics Corp (TSBX) – DWinneX - The Dwinnex

Financial Comparison: Turnstone Biologics (TSBX) and Its Rivals - Defense World

Head-To-Head Survey: Turnstone Biologics (TSBX) versus Its Competitors - Defense World

Turnstone Biologics reports Q1 EPS (85c), two estimates (77c)TipRanks.com - TipRanks

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - ForexTV.com

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights ... - wallstreet:online

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - Investing.com India

We're A Little Worried About Turnstone Biologics' (NASDAQ:TSBX) Cash Burn Rate - Simply Wall St

Turnstone Biologics appoints new board member By Investing.com - Investing.com Nigeria

Turnstone Biologics Corp. (NASDAQ:TSBX) institutional investors have had a good week as stock gains 34% - Yahoo Finance

PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight - GlobeNewswire

Biopharma IPO class of 2023 ends the year with performance up 7% - BioWorld Online

Thinking about buying stock in Evaxion Biotech, Macy's, Ford Motor, Marvell Technology, or Turnstone Biologics? - PR Newswire

TA Associates bets on software for community banks; plus an exclusive look at Paul Hastings’ IPO report - PE Hub

TSBXに似た銘柄